BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18088877)

  • 1. Impact of postmenopausal osteoporosis on the oral and maxillofacial surgery patient.
    Glowacki J
    Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):187-98, vi. PubMed ID: 18088877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of osteoporosis.
    Riggs BL
    West J Med; 1991 Jan; 154(1):63-77. PubMed ID: 2024511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early menopause on bone mineral density and fractures.
    Gallagher JC
    Menopause; 2007; 14(3 Pt 2):567-71. PubMed ID: 17476146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone and aging: effects on the maxillofacial skeleton.
    Kloss FR; Gassner R
    Exp Gerontol; 2006 Feb; 41(2):123-9. PubMed ID: 16412598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
    Rasheed A; Khurshid R; Aftab L
    J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis: pathophysiology and non-pharmacological management.
    Mundy GR
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):727-45. PubMed ID: 11812018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender specificity and osteoporosis.
    Bilezikian JP
    J Gend Specif Med; 2000 Oct; 3(7):6-12. PubMed ID: 11252929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for measuring bone density].
    Haberkamp M; Allolio B
    Med Klin (Munich); 1992 Mar; 87(3):131-8. PubMed ID: 1579090
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature.
    LaFleur J; McAdam-Marx C; Kirkness C; Brixner DI
    Ann Pharmacother; 2008 Mar; 42(3):375-86. PubMed ID: 18230704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of primary hyperparathyroidism in the management of osteoporosis.
    Saleem TF; Horwith M; Stack BC
    Otolaryngol Clin North Am; 2004 Aug; 37(4):751-61, viii-ix. PubMed ID: 15262513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for patients with low bone mass: the younger postmenopausal female.
    Honig S
    Bull NYU Hosp Jt Dis; 2008; 66(3):240-3. PubMed ID: 18937639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoporosis of the elderly person].
    Rivier E
    Rev Med Suisse Romande; 1996 Sep; 116(9):743-50. PubMed ID: 8966476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of age-related bone loss and bone fragility: an alternative view.
    Raisz LG; Seeman E
    J Bone Miner Res; 2001 Nov; 16(11):1948-52. PubMed ID: 11697790
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeletal implications of reproductive aging.
    Freeman R
    Semin Reprod Med; 2010 Sep; 28(5):422-5. PubMed ID: 20865656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis.
    Blain H; Chavassieux P; Portero-Muzy N; Bonnel F; Canovas F; Chammas M; Maury P; Delmas PD
    Bone; 2008 Nov; 43(5):862-8. PubMed ID: 18708176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.